Evidence map›Paper›PMID 25152446›Full record

ArticleJournal of neuroscience methods2014

AAV-mediated targeting of gene expression to the peri-infarct region in rat cortical stroke model.

Kert Mätlik, Usama Abo-Ramadan, Brandon K Harvey, Urmas Arumäe, Mikko Airavaara

Abstract read
In one paragraph

Article in Journal of neuroscience methods, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Kert MätlikInstitute of Biotechnology, University of Helsinki, FIN-00014 Helsinki, Finland.
Usama Abo-RamadanInstitute of Biotechnology, University of Helsinki, FIN-00014 Helsinki, Finland.
Brandon K HarveyIntramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA.
Urmas ArumäeInstitute of Biotechnology, University of Helsinki, FIN-00014 Helsinki, Finland; Department of Gene Technology, Tallinn University of Technology, Akadeemia tee 15, Tallinn 12618, Estonia.
Mikko AiravaaraInstitute of Biotechnology, University of Helsinki, FIN-00014 Helsinki, Finland. Electronic address: mikko.airavaara@helsinki.fi.
University of Helsinki · FINational Institute on Drug Abuse · USTallinn University of Technology · EE

Funding

Optogenetics and Transgenic Technology CoreZICDA000555 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2009 to 2017
$10.0M
Gene Therapy And NeurodegenerationZIADA000443 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2009 to 2020
$2.7M
Intramural NIH HHS ZIA DA000443Intramural NIH HHS ZIC DA000555
6 · The paper itself

Abstract

backgroundFor stroke patients the recovery of cognitive and behavioral functions is often incomplete. Functional recovery is thought to be mediated largely by connectivity rearrangements in the peri-infarct region. A method for manipulating gene expression in this region would be useful for identifying new recovery-enhancing treatments. NEW

methodWe have characterized a way of targeting adeno-associated virus (AAV) vectors to the peri-infarct region of cortical ischemic lesion in rats 2days after middle cerebral artery occlusion (MCAo).

resultsWe used magnetic resonance imaging (MRI) to show that the altered properties of post-ischemic brain tissue facilitate the spreading of intrastriatally injected nanoparticles toward the infarct. We show that subcortical injection of green fluorescent protein-encoding dsAAV7-GFP resulted in transduction of cells in and around the white matter tract underlying the lesion, and in the cortex proximal to the lesion. A similar result was achieved with dsAAV7 vector encoding the cerebral dopamine neurotrophic factor (CDNF), a protein with therapeutic potential. COMPARISON WITH EXISTING

methodsViral vector-mediated intracerebral gene delivery has been used before in rodent models of ischemic injury. However, the method of targeting gene expression to the peri-infarct region, after the initial phase of ischemic cell death, has not been described before.

conclusionsWe demonstrate a straightforward and robust way to target AAV vector-mediated over-expression of genes to the peri-infarct region in a rat stroke model. This method will be useful for studying the action of specific proteins in peri-infarct region during the recovery process.

Indexed as

Gene ExpressionGenetic VectorsAnimalsBrainBrain IschemiaDependovirusDisease Models, AnimalGenetic TherapyGreen Fluorescent ProteinsImmunohistochemistryInfarction, Middle Cerebral ArteryMagnetic Resonance ImagingMaleMetal NanoparticlesNerve Growth FactorsRats, Sprague-DawleyCDNF protein, ratGreen Fluorescent ProteinsNerve Growth FactorsAdeno-associated virusAnimal modelsFocal ischemiaFunctional recoveryGene transferPeri-infarct region

Identifiers

PMID25152446
PMCPMC4212894
OpenAlexW2138192657

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.